Studies have shown that Cyclin D1 is particularly overexpressed in complex hyperplasia and endometrioid carcinoma, whereas lower expression is more commonly associated with high-grade subtypes like serous carcinoma, which may follow alternative oncogenic pathways [9]. This evidence concerns the gene CCND1 and serous adenocarcinoma.